Source:http://linkedlifedata.com/resource/pubmed/id/19506468
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-7-7
|
pubmed:abstractText |
Acute respiratory distress syndrome (ARDS) is characterized by diffuse inflammation in the lung and resultant permeability edema. Polymyxin B-immobilized fiber (PMX-F) hemoperfusion is effective for sepsis-induced ARDS. High mobility group box-1 protein (HMGB1) is newly recognized as a proinflammatory cytokine. The aim of the study was to determine whether blood HMGB1 levels are increased in patients with ARDS and whether PMX-F treatment affects these levels. Subjects were 20 sepsis-induced patients with ARDS treated by PMX-F column and 20 age-matched healthy volunteers. Polymyxin B-immobilized fiber treatment was carried out twice at a rate of 100 ml/min for 2 hours. Systolic and diastolic blood pressures, the PaO2/FiO2 (PF) ratio and endotoxin, HMGB1, and urinary 8-hydroxy-2'-deoxyguanosine (OHdG) levels were measured before and after PMX-F treatment. Blood endotoxin levels, blood HMGB1 levels, and urinary 8-OHdG levels were significantly higher in patients with ARDS than in healthy volunteers. Systolic and diastolic blood pressures and the PF ratio increased significantly after PMX-F treatments. Polymyxin B-immobilized fiber treatment reduced blood endotoxin, blood HMGB1, and urinary 8-OHdG levels significantly. These data suggest that HMGB1 and oxidative stress play a role in the pathogenesis of ARDS and that PMX-F treatment may ameliorate increased blood HMGB1 and urinary 8-OHdG levels in patients with ARDS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/8-hydroxy-2'-deoxyguanosine,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyguanosine,
http://linkedlifedata.com/resource/pubmed/chemical/Endotoxins,
http://linkedlifedata.com/resource/pubmed/chemical/HMGB1 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Polymyxin B
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1538-943X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
395-9
|
pubmed:meshHeading |
pubmed-meshheading:19506468-Aged,
pubmed-meshheading:19506468-Anti-Bacterial Agents,
pubmed-meshheading:19506468-Blood Pressure,
pubmed-meshheading:19506468-Deoxyguanosine,
pubmed-meshheading:19506468-Edema,
pubmed-meshheading:19506468-Endotoxins,
pubmed-meshheading:19506468-Female,
pubmed-meshheading:19506468-HMGB1 Protein,
pubmed-meshheading:19506468-Hemoperfusion,
pubmed-meshheading:19506468-Humans,
pubmed-meshheading:19506468-Male,
pubmed-meshheading:19506468-Middle Aged,
pubmed-meshheading:19506468-Oxidative Stress,
pubmed-meshheading:19506468-Polymyxin B,
pubmed-meshheading:19506468-Respiratory Distress Syndrome, Adult,
pubmed-meshheading:19506468-Sepsis
|
pubmed:articleTitle |
Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome.
|
pubmed:affiliation |
Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan.
|
pubmed:publicationType |
Journal Article
|